{"id":60550,"date":"2024-10-15T00:05:10","date_gmt":"2024-10-15T00:05:10","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/10\/15\/40-billion-facial-injectables-market-outlook-2037-botulinum-toxin-type-a-products-particularly-in-the-u-s-will-generate-the-most-revenue\/"},"modified":"2024-10-15T00:05:10","modified_gmt":"2024-10-15T00:05:10","slug":"40-billion-facial-injectables-market-outlook-2037-botulinum-toxin-type-a-products-particularly-in-the-u-s-will-generate-the-most-revenue","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/40-billion-facial-injectables-market-outlook-2037-botulinum-toxin-type-a-products-particularly-in-the-u-s-will-generate-the-most-revenue\/","title":{"rendered":"$40+ Billion Facial Injectables Market Outlook, 2037: Botulinum Toxin Type A Products, Particularly in the U.S., Will Generate the Most Revenue"},"content":{"rendered":"
\n

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) — The “Global Facial Injectables Market Outlook 2037”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.<\/p>\n

The global market for facial injectables is poised to rise at a CAGR of 10.86% over the forecast period, i.e., 2025-2037. This growth of the market is set to be dominated by a growing geriatric population along with growing consciousness among people regarding beauty. Furthermore, the market is also projected to rise on account of the rising trend of minimally invasive surgeries and the surging advancement of facial injectables. The market is estimated to capture a revenue of about USD 40 billion by the end of 2037, up from a revenue of more than USD 10 billion in the year 2024.<\/p>\n

The global market for facial injectables is segmented into numerous segments including product, application, and end-user. By product, the market for facial injectables is further segmented into collagen, hyaluronic acid [HA], botulinum toxin type A, calcium hydroxylapatite [CaHA], and polymer fillers. Amongst these, the botulinum toxin type A segment is predicted to generate the largest market revenue of USD 20 billion by the end of 2037. This could be owing to its ability to prevent repetitive muscular spasms.<\/p>\n

On the basis of region, the global facial injectables market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is projected to gather the highest market revenue of over USD 14 billion by the end of 2037, up from a revenue of close to USD 3 billion in the year 2024. This growth of the market in this region is poised to be encouraged by growing spending on cosmetics.<\/p>\n

Some of the prominent industry leaders in the global facial injectables market that are included in the report are:<\/strong><\/p>\n